Prevention of dementia: lessons from SYST-EUR and PROGRESS

Elias, 1993, Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study, Am. J. Epidemiol., 138, 353, 10.1093/oxfordjournals.aje.a116868 Kilander, 1998, Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men, Hypertension, 31, 780, 10.1161/01.HYP.31.3.780 Knopman, 2001, Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults, Neurology, 56, 42, 10.1212/WNL.56.1.42 Skoog, 1996, 15-year longitudinal study of blood pressure and dementia, Lancet, 347, 1141, 10.1016/S0140-6736(96)90608-X Launer, 2000, Midlife blood pressure and dementia: the Honolulu–Asia aging study, Neurobiol. Aging, 21, 49, 10.1016/S0197-4580(00)00096-8 Tzourio, 1999, Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging, Neurology, 53, 1948, 10.1212/WNL.53.9.1948 Murray, 2002, Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans, Arch. Intern. Med., 162, 2090, 10.1001/archinte.162.18.2090 Prince, 1996, Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults, BMJ, 312, 801, 10.1136/bmj.312.7034.801 1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP), JAMA, 265, 3255, 10.1001/jama.265.24.3255 Di Bari, 2001, Dementia and disability outcomes in large hypertension trials: lessons learned from the Systolic Hypertension in the Elderly Program (SHEP) Trial, Am. J. Epidemiol., 153, 72, 10.1093/aje/153.1.72 Forette, 1998, Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial, Lancet, 352, 1347, 10.1016/S0140-6736(98)03086-4 Tzourio, 2003, PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease, Arch. Intern. Med., 12;163, 1069 Forette, 2002, Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study, Arch. Intern. Med., 162, 2046, 10.1001/archinte.162.18.2046 Khachaturian, 1994, Calcium hypothesis of Alzheimer's disease and brain aging, Ann. N.Y. Acad. Sci., 747, 1, 10.1111/j.1749-6632.1994.tb44398.x Mason, 1999, Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells, J. Neurochem., 72, 1448, 10.1046/j.1471-4159.1999.721448.x Zipfel, 1999, Reducing calcium overload in the ischemic brain, N. Engl. J. Med., 341, 1543, 10.1056/NEJM199911113412011 Kawahara, 2001, Intracellular calcium changes in neuronal cells induced by Alzheimer's beta-amyloid protein are blocked by estradiol and cholesterol, Cell. Mol. Neurobiol., 21, 1, 10.1023/A:1007168910582 O'Neill, 2001, Dysfunctional intracellular calcium homoeostasis: a central cause of neurodegeneration in Alzheimer's disease, Biochem. Soc. Symp., 67, 177, 10.1042/bss0670177 Mattson, 1992, β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci., 12, 376, 10.1523/JNEUROSCI.12-02-00376.1992 Veinbergs, 2002, Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis, J. Neurosci. Res., 67, 379, 10.1002/jnr.10138 Mattson, 2000, Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis, J. Neurosci., 20, 1358, 10.1523/JNEUROSCI.20-04-01358.2000 Sabbatini, 2001, Effect of nicardipine treatment on the expression of neurofilament 200 kDa immunoreactivity in the brain of spontaneously hypertensive rats, Clin. Exp. Hypertens., 23, 127, 10.1081/CEH-100001204 Farkas, 2001, Calcium antagonists decrease capillary wall damage in aging hypertensive rat brain, Neurobiol. Aging, 22, 299, 10.1016/S0197-4580(00)00225-6 Vagnucci, 2003, Alzheimer's disease and angiogenesis, Lancet, 361, 605, 10.1016/S0140-6736(03)12521-4